Republic of the Philippines
Cebu Normal University
Osmeña Blvd. Cebu City, 6000 Philippines
College of Nursing
Center of Excellence (COE) | Level IV Re-Accredited (AACCUP)
Telephone No.: (032) 254 4837
Email: [email protected]/[email protected]
Website: www.cnu.edu.ph
Siasar, Kenn T. BSN III-A
Patient’s Initials:_KS__________________________ Date of Admission: November 22, 2020___________________ Diagnosis: Rat-bite Fever, Inguinal Lymphadenopathy
Age: 35 years old____________________________________ Height/Weight: Height: 5 ft 4 in; Weight 55 kgs Clinical Intervention: __________________________________
Sex: Female Ward: Medical Bed No.: 5 Name of Physician: Dr. Lissa Mamoba ______________
Nursing
Name of Drug Classification Mechanism of Action Indication Contraindication Side Effects
Responsibilities
Generic Name: Therapeutic Acts on cell membrane General Indications: Contraindication: CNS: Headache, Before
Silver sulfadiazine classification: and cell wall; its Treatment of acute Contraindicated with peripheral neuropathy, 1. Wash hands before
Antibacterial (Topical) bactericidal for many infections caused by allergy to sulfonamides, mental depression, and after instillation
Trade Name: gram-positive and gram- susceptible organisms: sulfonylureas, thiazides; seizures, ataxia, of topical
Dermazin, Flamazine, Pharmacologic negative organisms. UTIs, chancroid, pregnancy (teratogenic; hallucinations, medication.
Hydrogel Ag, Silvadene, classification: inclusion conjunctivitis, may cause kernicterus); tinnitus, vertigo,
Thermazene Broad-Spectrum Pharmacokinetics: trachoma, nocardiosis, lactation (risk of 2. Check doctor’s
insomnia, hearing
sulfonamide Absorption: Slowly toxoplasmosis (with kernicterus, diarrhea, loss, drowsiness, order and patient’s
Patient’s Dose: releases sulfadiazine pyrimethamine), malaria rash). transient lesions of chart.
Apply onto affected area Pregnancy category: when it comes into (as adjunctive therapy posterior spinal 3. Obtain bacterial
BID for clean debrided B contact with wound for chloroquine-resistant Precautions: column, transverse C&S tests prior to
burn wounds exudates. Up to 10% of strains of Plasmodium Use cautiously with myelitis and during therapy.
sulfadiazine may be falciparum), acute otitis impaired renal or hepatic Dermatologic: 4. Assess history for
Route: absorbed. media (due to function, G6PD Photosensitivity,
Topical Distribution: Unknown. Haemophilus influenzae deficiency, porphyria. hypersensitivity to
cyanosis, petechiae,
Metabolism and when used with alopecia sulfonamides.
Form: Excretion: Unknown. penicillin or Drug Interactions GI: Nausea, emesis, 5. Instruct pregnant
Topical cream Half-life: 10 hr erythromycin), H. Drug-drug. abdominal pains, patient to avoid
influenza meningitis (as Increased risk of diarrhea, bloody drug.
Maximum Dose: Onset: unknown adjunctive therapy with hypoglycemia when diarrhea, anorexia,
Apply onto affected area Peak: Unknown parenteral streptomycin), tolbutamide, pancreatitis, During
with cream twice a day Duration: Unknown meningococcal tolazamide, stomatitis, impaired 1. Apply drug only on
meningitis, rheumatic glyburide, glipizide, folic acid absorption, affected areas
Minimum Dose: fever. acetohexamide, hepatitis,
Apply onto affected area chlorpropamide are hepatocellular
with cream once a day Orphan drug use: With taken concurrently. necrosis 2. Bathe patient daily.
pyrimethamine for Increased risk of GU: Crystalluria, 3. Clean site before
Availability: treatment of phenytoin toxicity hematuria, applying the
Prescription-only white Toxoplasma gondii with sulfonamides proteinuria, nephrotic medication.
cream: 20g, 50g, 85g, encephalitis Risk of hemorrhage syndrome, toxic
400g, 1000g in patients with AIDS 4. Use gloves in
when combined nephrosis with
with oral oliguria and anuria, applying the
Contents: Patient’s indication: anticoagulants oligospermia, medication on site.
White petrolatum, Bacterial infection due Increased risk of infertility 5. Inspect patient’s
stearyl alcohol, to Spirillum minus nephrotoxicity with Hematologic: skin daily, and note
isopropyl myristate, cyclosporine and Hemolytic anemia, any changes.
sorbitan monooleate, decreased hypoprothrombinemia,
polyoxyl 40 stearate, cyclosporine effect methemoglobinemia, After
propylene glycol, and megaloblastic anemia 1. Instruct patient to
water, with Drug-diagnostic tests. Hypersensitivity: promptly report
methylparaben 0.3% as False-positive urinary Stevens-Johnson
a preservative adverse reaction,
glucose tests using syndrome,
Benedict method generalized skin especially burning
eruptions, epidermal or excessive pain.
necrolysis, urticaria, 2. Inform patient of
serum sickness, need for frequent
pruritus, exfoliative blood and urine
dermatitis, tests.
anaphylactoid
3. Tell patient that he
reactions, periorbital
edema, conjunctival may develop
and scleral redness, sensitivity to the
photosensitization, sun.
arthralgia, allergic 4. Tell patient to
myocarditis, transient continue treatment
pulmonary changes until satisfactory
with eosinophilia,
healing occurs.
decreased pulmonary
function
Other: Drug fever,
chills, periarteritis
nodosum
Source: Source:
Source: Source: Source: Source: Karch, A. M. Karch, A. M. (2013). 2014 Source:
Kizior, R. J., & Vallerand, A., & Kizior, R. J., & Kizior, R. J., & (2013). 2014 Lippincott's Pocket Drug Vallerand, A., &
Hodgson, B. B. (2018). Sanoski, C. (2017). Hodgson, B. B. (2018). Hodgson, B. B. (2018). Lippincott's Pocket Guide for Nurses. Sanoski, C. (2017).
Saunders Nursing Drug Davis's Drug Guide for Saunders Nursing Drug Saunders Nursing Drug Drug Guide for Nurses. Lippincott Williams & Davis's Drug Guide for
Handbook 2019 E-Book. Nurses. 16th ed. Handbook 2019 E-Book. Handbook 2019 E-Book. Lippincott Williams & Wilkins. Nurses. 16th ed.
Elsevier Health Philadelphia: F.A. Davis Elsevier Health Elsevier Health Wilkins. Philadelphia: F.A. Davis
Sciences. Company. Sciences. Sciences. Company.
Vallerand, A., & Vallerand, A., &
Sanoski, C. (2017). Sanoski, C. (2017).
Davis's Drug Guide for Davis's Drug Guide for
Nurses. 16th ed. Nurses. 16th ed.
Philadelphia: F.A. Davis Philadelphia: F.A. Davis
Company. Company.
Drug Study Scoring 10 pts.
Name of Drug 1 pts.
Classification 1 pts.
Mechanism of Action 1 pts.
Indication 1 pts.
Contraindication 1 pts.
Side Effects 1 pts.
Nursing Responsibilities 3 pts.
1 pts. (at least 2
Sources
references)
Scoring System Criterion Reference: 70%
